Introduction

Asthma and its pathophysiology
Asthma is the most common chronic diseases that affect childhood and is the main cause of morbidity in adults. Epidemiological data show that this illness affects 4%-17% children and 7.7% adults in the United States. Furthermore, almost 300 million people worldwide could be affected by asthma 1 . In Brazil, Salvador has extremely high rates of up to 24.6% among school-age children (13-14 years) 2 . Studies have shown that asthma develops during the intrauterine foetal programming 3 . Atopic asthma is most frequent in children because there is a predominant immunological Th2 response at this stage of life 4 . This condition is an inflammatory disease, leading to airway obstruction, hyper-response, heightened mucus production, and it can affect remodelling of the airway wall. The increasing number of studies about this pathology allowed a paradigm shift in immunology and molecular biology that led to an extensive analysis of inflammatory cells and mediators involved in the pathophysiology of asthma. The pathophysiological characteristics of asthma are not limited to the Th2 response. Studies have shown that the immune response also involves T helper cells (Th)-17, Th9, as well as the Th1 and Th33 profile
5
. The Th2 response is characterised by the production of Th2 cytokines; interleukin-4 (IL-4) and IL-13 are main cytokines responsible for the stimulation of plasma cells to secrete IgE and continue the inflammatory process. IL-4 also stimulates increased expression of IgE receptors on mast cells, eosinophils and basophils 6 . Other mediators are also involved in the inflammatory process, such as Tumour Necrosis Factor(TNF) and nitric oxide released by macrophages which produce neutrophil elastase. Rather than Th2-type cytokines, it has been well documented that IL-2, IL-12, interferon-γ (IFN-γ), TNF-α and transforming growth factor-β (TGF-β) produced by CD4+ T helper 1 cells (Th1) are implicated in the pathogenesis of asthma [5] [6] [7] [8] . Epithelial cells in repair phase produce TGF-β, fibroblast growth factor and endothelin, which regulate fibroblasts and myofibroblasts to release collagen, elastic fibre, proteoglycan and glycoprotein, and these substances induce airway wall thickening 9 . Antigen-presenting cells, especially dendritic cells (DCs), play a critical role in initiating and regulating early inflammatory events at epithelial surfaces and control the recruitment and activation of Th2 cells 6, 10 . A cooperation of airway epithelium and DC controls asthma development, and Th2 activation requires DC-mediated antigen presentation. Thus, cytokines such as IL-33 are induced
. IL-33 is a member of the IL-1 family that can induces activation of DCs, mast cells, eosinophils and basophils, ultimately leading to increased expression of Th2-associated cytokines and IgE. In addition, IL-33 administration provokes hypertrophy of bronchial epithelial cells, as well as mucus secretion 11, 12 . . Based on the central role of TGF-β, especially on its ability to modulate various immunological profiles,the aim of this review was to discuss whether TGF-β gene polymorphisms are associated with asthma risk.
Discussion
The authors have referenced some of their own studies in this review. These referenced studies have been conducted in accordance with the Declaration of Helsinki (1964) , and the protocols of these studies have been approved by the relevant ethics committees related to the institution in which they were performed. All human subjects, in these referenced studies, gave informed consent to participate in these studies.
TGF-β
TGF-β is a pleiotropic and multifunctional growth factor released by several immunologic cells (epithelial cells, eosinophils, Th2 lymphocytes, macrophages and fibroblast) showing key roles in immune response on homeostasis, infections and inflammatory diseases through its immune modulatory and fibrogenic activity 13 . The TGF-β superfamily consists of more than 33 members, all holding a similar prodomain fold, including bone morphogenetic proteins (BMPs), growth and differentiation factors (GDFs), activins and inhibins 14 . The TGF-β family has three different TGF-β isoforms in mammals: TGF-β1, the most prevalent isoform, TGF-β2 and TGF-β3 that have similar properties in vitro 14, 15 . TGF-β is the main regulator of the immune response and exerts potent anti-inflammatory activity by inhibiting the differentiation of immune cells (Th1, Th2, cytotoxic T cells and B cells) as well as inhibition of cytokine production (IFN-γ and IL-2) 15, 16 . Furthermore, it acts as an important differentiating factor for some cells that exert powerful immunosuppressive effects, such as regulatory T cells (Treg cells) FOXP3+ [17] [18] [19] . Additionally, TGF-β1 plays an important role in extracellular matrix remodelling and fibrosis through the induction of target genes such as connective tissue growth factor (CTGF), α-smooth muscle actin (α-SMA), collagen 1a2 (col1a2) 20 inducing proliferation and chemo attraction of fibroblasts and their differentiation into myofibroblasts, which finally will induce fibrosis and contraction of the extracellular matrix 13 . 21, 22 . Treg cells are essential in the maintenance of immunological tolerance to self-antigens and in the regulation of the immune response to infectious organisms and represent a major pathway proposed to keep immune Review asthma or other allergies 33, 39 . Although these data seem controversial, this single-nucleotide polymorphism (SNP) can be an interesting marker for allergic diseases. However, more studies are needed to better understand the results obtained so far. Lack of associations can be achieved when sample size is small and therefore may have lacked power to detect statistically significant associations. Moreover this polymorphism was associated with IgE levels. One study described phenotypic association between total IgE levels in serum and -509 C > T(39) and also association with persistent IgE-mediated cow's milk allergy in children 40 .
TGF-β and asthma immune response
rs2241712 (-10807 G > A)
The rs2241712 (-10807) is located in the promoter region of the TGF-β1 gene and has been associated with some respiratory diseases such as asthma and chronic obstructive pulmonary disease (COPD) 41 (Table 1) . Studies have analysed associations between rs2241712 and asthma. In one of these studies, the authors have shown an association between rs2241712 and asthma in atopic subjects. The G/A genotype was associated with decreasing asthma risk; however, this association was not statistically significant 38 . Furthermore in a study conducted in Costa Rica revealed an association of the A allele with increased airway responsiveness 42 . However, another study showed an association between the G allele with asthma risk, but this difference was not statistically significant 38 . It seems that this SNP may have an important role in the respiratory disease development. Therefore more studies are needed to elicit this association. Although the relationship between rs2241712 and TGF-β1 serum levels has not been evaluated, this polymorphism presents score 2b in the RegulomeDB database being likely to affect binding to transcription factor and, potentially, change the TGF-β1 production (Table 1) . homeostasis in the airways. Thus, recently, attention has been given to Treg cells producing IL-10 and TGF-β. These immune modulatory cytokines can down regulate the production of both Th1 and Th2 cytokines and suppress the inflammatory response on asthma (Figure 1 The neutralisation of TGF-β in two different models of chronic allergen challenge-reduced airway remodelling 30 . Asthmatic patients showed increased TGF-β expression in both bronchial biopsy sections and bronchoalveolar lavage in comparison with normal subjects and expression correlated with the lung fibrosis degree 31 . These data reinforce the idea that TGF-β acts to regulate immune response in the lungs and that perturbations in the level of expression of that cytokine or even in one of the TGF-β signalling pathway molecules may have severe consequences for maintenance of pulmonary homeostasis. However, many studies have investigated the rationale that increased TGF-β expression may be associated with asthma severity by increasing airway remodelling.
TGF-β gene polymorphisms and allergic disease risk
Polymorphisms in gene sequences can affect the expression of proteins in various ways: levels of gene transcription, splicing, stability and levels of mRNA translation 32 . Polymorphisms in genes that participate on immunity may influence the development of several diseases. Susceptibility to many diseases is associated with a particular 'pro-inflammatory' profile, which can be explained by individual genetic determinants. TGF-β1 is an important replicated asthma candidate gene, and few studies have evaluated the direct association of TGF-β polymorphisms and risk to allergic diseases, in particular, asthma 33, 34 . The TGF-β gene is located on chromosome 19q13.1-13.3 35 , and some polymorphisms were shown in this gene and can be found in exons, introns and promoter gene sequences. The most studied polymorphisms on TGF-β gene are described in Table 1 . Below we present some of them and discuss their role on cytokine levels as well as on asthma development:
rs1800469 (-509 C > T)
The -509 C > T polymorphism is located in the promoter region of TGFB1 and can modulate TGF-β1 function and circulating TGF-β1 levels 34 ( Table 1 ). The T allele has been associated with higher TGF-β1 plasma levels 36 . An interesting Genome-wide association study (GWAS) previously reported that -509 C > T was associated with asthma in a Mexican population 37 . These results were consistent with several authors 34, 38 . In contrast, other authors found no association between -509 polymorphisms and risk to clinically manifested atopic Licensee OA Publishing London 2013. Creative Commons Attribution License (CC-BY) Review rs1800468 (-800 G > A) We found only one study that analysed the SNP-800 in association with asthma and serum IgE levels 33 . Moreover, the authors found no association between the SNP-800 and clinical manifestation of atopic diseases and serum IgE levels (Table 1) .
rs1800470 (869 T > C)
The rs1800470 is located in codon 10 of exon 1 and is related to change the amino acid sequence, leucine to proline in the signal peptide 43 . Codon 10 polymorphism has been studied in several diseases as nephropathy in Type 1 diabetes 44 , allergic rhinitis 45 and asthma 34 . The 869 polymorphism was found to be associated with an increased circulating TGF-β1 concentration 46 , increased production of TGF-β1 in vitro 47 and increased risk of asthma 34 (Table 1) .
rs1800471 (codon 25)
The 915 G > C polymorphism results in an amino acid change (arginine to proline) at codon 25; however, the functional impact of this polymorphism is unknown (Table 1) . In allergic diseases, no association was found for this SNP 45 . Although, the haplotype analysis including rs1800471 (codon 10) was associated with a history of parental asthma 45 .
Conclusion
Several SNPs on TGF-β1 have been studied in asthma diseases. Some SNPs were positively associated with asthma but not always replicated by all authors. Although these data seem controversial, polymorphisms on TGF-β1 may be an interesting marker for asthma since it is related to an increase on TGF-β1 levels, and it may be related to tissue remodelling. However, more studies are required to better understand the results observed so far. It is important to point out that in some studies, lack of associations can be related to small sample size and consequently no power to detect statistically significant associations. Moreover, the prevalence of these polymorphisms may vary from population to population, which can also interfere with these controversial results. Greater sample size and studies using a considerable number of informative ancestry markers are required to confirm these findings and also to identify populations, where TGF-β1 variants are mediating the casual pathway of allergic diseases, in special, asthma.
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